These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7221403)

  • 1. Spectrum of platelet aggregation abnormalities in myeloproliferative diseases.
    Cortelazzo S; Viero P; Bassan R; Barbui T
    Ric Clin Lab; 1981; 11(1):35-42. PubMed ID: 7221403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
    Yamamoto K; Sekiguchi E; Takatani O
    Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K; Huzoor-Akbar
    Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of platelet aggregation in chronic myeloproliferative disorders.
    Avram S; Lupu A; Angelescu S; Olteanu N; Mut-Popescu D
    J Cell Mol Med; 2001; 5(1):79-87. PubMed ID: 12067453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia.
    Gerrard JM; Stoddard SF; Shapiro RS; Coccia PF; Ramsay NK; Nesbit ME; Rao GH; Krivit W; White JG
    Br J Haematol; 1978 Dec; 40(4):597-607. PubMed ID: 281970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation in whole blood from patients with Glanzmann's thrombasthenia.
    Burgess-Wilson ME; Cockbill SR; Johnston GI; Heptinstall S
    Blood; 1987 Jan; 69(1):38-42. PubMed ID: 3098326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function in the neonate.
    Stuart MJ
    Am J Pediatr Hematol Oncol; 1979; 1(3):227-34. PubMed ID: 543516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders.
    Balduini CL; Bertolino G; Noris P; Piletta GC
    Am J Clin Pathol; 1991 Jan; 95(1):82-6. PubMed ID: 1987755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative platelet defects in chronic myeloproliferative disorders: evidence for reduced ATP secretion.
    Löfvenberg E; Nilsson TK
    Eur J Haematol; 1989 Nov; 43(5):435-40. PubMed ID: 2612617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myeloproliferative disorders: improved platelet aggregation following venesection.
    Boughton BJ
    Br J Haematol; 1978 Aug; 39(4):589-98. PubMed ID: 698130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative platelet defect in a case of heparin-induced thrombocytopenia.
    Chong BH; Grace CS; Rozenberg MC; Castaldi PA
    Scand J Haematol; 1983 May; 30(5):427-9. PubMed ID: 6407097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemostatic mechanisms of the newborn foal: reduced platelet responsiveness.
    Clemmons RM; Dorsey-Lee MR; Gorman NT; Sturtevant FC
    Equine Vet J; 1984 Jul; 16(4):353-6. PubMed ID: 6434303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of platelet aggregation study in myeloproliferative disorders.
    Kueh YK; Chan L; Lim BC; Suri R; Tan YO
    Ann Acad Med Singap; 1983 Jul; 12(3):466-71. PubMed ID: 6611104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of aggregation, thromboxane A2 synthesis, and 14C serotonin release in platelets of patients with idiopathic scoliosis.
    Floman Y; Liebergall M; Robin GC; Eldor A
    Spine (Phila Pa 1976); 1983 Apr; 8(3):236-41. PubMed ID: 6623192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
    Smith IL; Martin TJ
    Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the equine platelet aggregation response.
    Meyers KM; Lindner C; Grant B
    Am J Vet Res; 1979 Feb; 40(2):260-4. PubMed ID: 464363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-tocopherol: its inhibition on human platelet aggregation.
    Fong JS
    Experientia; 1976 May; 32(5):639-41. PubMed ID: 1278322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.